drugset / Trial / NCT01894399
Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects
RandomizedSingle-groupOpen-labelTreatment
Summary
Study Design * Open, escalating single-dose design. * 7 ascending dose cohorts * In each cohorts, subjects will receive a single dose of HM61713. * Main objective of this study is to evaluate the pharmacokinetics of HM61713 tablet.
Timeline
- Start
- 2013-09
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olmutinib | Small molecule | 100 mg | — |
| Subject | Olmutinib | Small molecule | 200 mg | — |
| Subject | Olmutinib | Small molecule | 300 mg | — |
Indications
No indication recorded.